Blood Cancer Journal (Apr 2022)
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”
- K. H. Begna,
- X. Xu,
- N. Gangat,
- H. Alkhateeb,
- M. M. Patnaik,
- A. Al-Kali,
- M. A. Elliott,
- W. J. Hogan,
- M. R. Litzow,
- C. C. Hook,
- A. P. Wolanskyj-Spinner,
- A. Mangaonkar,
- R. He,
- A. Pardanani,
- M. Shah,
- R. P. Ketterling,
- A. Tefferi
Affiliations
- K. H. Begna
- Department of Internal Medicine and Division of Hematology
- X. Xu
- Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic
- N. Gangat
- Department of Internal Medicine and Division of Hematology
- H. Alkhateeb
- Department of Internal Medicine and Division of Hematology
- M. M. Patnaik
- Department of Internal Medicine and Division of Hematology
- A. Al-Kali
- Department of Internal Medicine and Division of Hematology
- M. A. Elliott
- Department of Internal Medicine and Division of Hematology
- W. J. Hogan
- Department of Internal Medicine and Division of Hematology
- M. R. Litzow
- Department of Internal Medicine and Division of Hematology
- C. C. Hook
- Department of Internal Medicine and Division of Hematology
- A. P. Wolanskyj-Spinner
- Department of Internal Medicine and Division of Hematology
- A. Mangaonkar
- Department of Internal Medicine and Division of Hematology
- R. He
- Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic
- A. Pardanani
- Department of Internal Medicine and Division of Hematology
- M. Shah
- Department of Internal Medicine and Division of Hematology
- R. P. Ketterling
- Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic
- A. Tefferi
- Department of Internal Medicine and Division of Hematology
- DOI
- https://doi.org/10.1038/s41408-022-00654-0
- Journal volume & issue
-
Vol. 12,
no. 4
pp. 1 – 4
Abstract
No abstracts available.
